ArticleJournal of acquired immune deficiency syndromes (1999)2019

High Plasma Soluble CD163 During Infancy Is a Marker for Neurocognitive Outcomes in Early-Treated HIV-Infected Children.

Sarah F Benki-Nugent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.